DK199183A - Quinolinderivater og fremgangsmaade til fremstilling deraf - Google Patents

Quinolinderivater og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK199183A
DK199183A DK199183A DK199183A DK199183A DK 199183 A DK199183 A DK 199183A DK 199183 A DK199183 A DK 199183A DK 199183 A DK199183 A DK 199183A DK 199183 A DK199183 A DK 199183A
Authority
DK
Denmark
Prior art keywords
procedures
preparing
quinoline derivatives
quinoline
derivatives
Prior art date
Application number
DK199183A
Other languages
English (en)
Other versions
DK199183D0 (da
Inventor
David James Le Count
Robert James Pearce
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838302236A external-priority patent/GB8302236D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK199183D0 publication Critical patent/DK199183D0/da
Publication of DK199183A publication Critical patent/DK199183A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

lige måder. Forbindelserne er 5-hydroxytryptaminantagonister og kan indgå i virksomme farmaceutiske midler, f.eks. sammen med et farmaceutisk fortyndingsmiddel eller barestof.
DK199183A 1982-05-04 1983-05-04 Quinolinderivater og fremgangsmaade til fremstilling deraf DK199183A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8212787 1982-05-04
GB8212787 1982-05-04
GB838302236A GB8302236D0 (en) 1983-01-27 1983-01-27 Heterocyclic compounds
GB8302236 1983-01-27

Publications (2)

Publication Number Publication Date
DK199183D0 DK199183D0 (da) 1983-05-04
DK199183A true DK199183A (da) 1983-11-05

Family

ID=26282723

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199183A DK199183A (da) 1982-05-04 1983-05-04 Quinolinderivater og fremgangsmaade til fremstilling deraf

Country Status (13)

Country Link
US (1) US4607039A (da)
EP (1) EP0093521B1 (da)
KR (1) KR840004726A (da)
DD (1) DD209817A5 (da)
DE (1) DE3377796D1 (da)
DK (1) DK199183A (da)
ES (1) ES522089A0 (da)
FI (1) FI831537L (da)
GB (1) GB8310261D0 (da)
GR (1) GR78484B (da)
IL (1) IL68513A0 (da)
NO (1) NO831562L (da)
PT (1) PT76630B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308601D0 (en) * 1983-03-29 1983-05-05 Ici Plc Heterocyclic compounds
JPH064584B2 (ja) * 1984-02-29 1994-01-19 沢井製薬株式会社 新規アニリド誘導体
US5179107A (en) * 1990-09-07 1993-01-12 Schering Corporation Antiviral quinolinone compounds
EP0549729B1 (en) * 1990-09-07 1997-12-17 Schering Corporation Antiviral compounds and antihypertensive compounds
US5190956A (en) * 1990-09-07 1993-03-02 Schering Corporation Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections
GB9022785D0 (en) * 1990-10-19 1990-12-05 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
FR2795645B1 (fr) 1999-06-30 2001-09-21 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
MY120631A (en) * 2000-09-08 2005-11-30 Union Pharma Scient Appl Novel pharmaceutical combination having analgesic activity
WO2007089634A2 (en) * 2006-01-30 2007-08-09 Merck & Co., Inc. Inhibitors of fatty acid synthase (fas)
US8680116B2 (en) * 2009-07-22 2014-03-25 Merck Sharp & Dohme Corp. Quinolinone PDE2 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US16394A (en) * 1857-01-13 Improvement in gotton-gins
DE430960C (de) * 1924-07-11 1926-06-23 J G Farbenindustrie Akt Ges Verfahren zur Darstellung von basischen AEthern von Chinolinderivaten
US1572768A (en) * 1925-06-26 1926-02-09 Winthrop Chem Co Inc Pharmaceutical product
GB349761A (en) * 1929-05-16 1931-06-04 Chem Ind Basel Manufacture of aminoalkoxy-derivatives of aryl-quinolines
US1860286A (en) * 1929-05-16 1932-05-24 Soc Of Chemical Ind Basic ethers of aryl-quinolines
US4035374A (en) * 1973-05-03 1977-07-12 Smith Kline & French Laboratories Limited Imidazolyl alkylaminopyridone and pyridinethione compounds
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4343805A (en) * 1978-12-16 1982-08-10 John Wyeth & Brother Limited Heterocyclic compounds
US4235909A (en) * 1979-04-19 1980-11-25 Eli Lilly And Company Octahydro-2H-pyrrolo[3,4-g]quinolines
CA1173037A (en) * 1980-03-01 1984-08-21 John L. Archibald Piperidino ureas as antidepressants
IN158970B (da) * 1981-06-09 1987-02-28 Ici Plc

Also Published As

Publication number Publication date
IL68513A0 (en) 1983-07-31
PT76630A (en) 1983-06-01
EP0093521A3 (en) 1984-08-01
US4607039A (en) 1986-08-19
EP0093521A2 (en) 1983-11-09
ES8502093A1 (es) 1984-12-16
KR840004726A (ko) 1984-10-24
DD209817A5 (de) 1984-05-23
ES522089A0 (es) 1984-12-16
PT76630B (en) 1985-12-03
DE3377796D1 (en) 1988-09-29
FI831537A0 (fi) 1983-05-04
DK199183D0 (da) 1983-05-04
EP0093521B1 (en) 1988-08-24
GR78484B (da) 1984-09-27
GB8310261D0 (en) 1983-05-18
FI831537L (fi) 1983-11-05
NO831562L (no) 1983-11-07

Similar Documents

Publication Publication Date Title
NL188219C (nl) Camptothecinederivaten, werkwijze voor het bereiden daarvan, farmaceutische preparaten met anti-tumorwerking, werkwijze voor het bereiden daarvan.
NL189193C (nl) N(benzyl)-2-dialkylpropaanamiden, werkwijze voor het bereiden daarvan, herbicide preparaten en werkwijze voor het bestrijden van ongewenste plantengroei.
NL7805763A (nl) Afdrukmateriaal, in het bijzonder voor tandheelkunde, alsmede werkwijze voor het bereiden daarvan.
IT8348422A0 (it) Composti eterociclici, procedimento per prpararli e composizioni farmaceutiche che li contengono
NO152846C (no) Molekylaert koordinasjonskompleks, samt fremgangsmaate for fremstilling derav.
NL7905375A (nl) Prostanoiden, werkwijze voor het bereiden daarvan, en daarop gebaseerde farmaceutische preparaten.
NL8402946A (nl) Antidepressieve 1,2,4-triazolon verbindingen; werkwijzen voor het bereiden daarvan; farmaceutische preparaten.
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
DK199183A (da) Quinolinderivater og fremgangsmaade til fremstilling deraf
NL7804966A (nl) Nieuwe alkyleendiaminederivaten en werkwijze voor het bereiden ervan.
DK572183A (da) 7-carboxymethoxyphenylacetamido-3-cephemderivater, fremgangsmaade til fremstilling deraf og antibakterielle praeparater indeholdende forbindelserne
ES512295A0 (es) Procedimiento para preparar derivados de piridina.
NL7802824A (nl) 11,12-seco-prostaglandinen alsmede werkwijze voor het bereiden daarvan.
MX14253A (es) Compuestos de amonio cuaternario, composiciones farmaceuticas que incluyen los compuestos y procedimiento para preparar los compuestos de amonio cuaternario.
NO842328L (no) Polyamidaminpolyaminer, samt fremgangsmaate ved fremstilling derav.
DK560884D0 (da) Enzym, fremgangsmaade til fremstilling deraf og anvendelse af enzymet
DK158569C (da) Traebeskyttelsesmiddelkoncentrat, heraf fremstillet middel og fremgangsmaade til koncentratets fremstilling
DK589483D0 (da) Mikrobiel loebe, fremgangsmade til fremstilling deraf og plasmider til anvendelse ved fremgangsmaden
NL175524C (nl) Glycerolderivaten, deze bevattende farmaceutische preparaten, en werkwijze voor het bereiden daarvan.
NL189136B (nl) Polymeersuspensie, werkwijze ter bereiding daarvan alsmede toepassing daarvan.
IT8248222A0 (it) Derivati pirazolici, procedimento per prepararli ed erbicidi che licontengono
DK567184D0 (da) Pyridonderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK490185A (da) 2-cyanbenzimidazol-derivater, fremgangsmaade til fremstilling af disse samt anvendelse af disse som fungicider og acaricider
DK222284A (da) 2-heterocyclyllavalkyl-2-penem-forbindelser og salte deraf samt fremgangsmaade til fremstilling deraf
NO812115L (no) Fortilsetning, og fremgangsmaate for fremstilling derav.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment